Literature DB >> 18810109

lontophoresis: Clinical Research in Musculoskeletal lnf lammatory Conditions.

P R Harris.   

Abstract

Fifty patients with various musculoskeletal inflammatory conditions were treated with iontophoresis (direct current 5 milliamperes, 20 minutes). The treatment drugs were 1 cubic centimeter, 4 milligrams per milliliter of dexamethasone sodium phosphate (Decadron) combined with 2 cubic centimeters of 4% Xylocaine. Thirty-eight of the 50 patients had an excellent relief of pain and symptoms, seven reported moderate relief, and five patients had little or no change. There were no significant side effects. It was concluded that iontophoresis is an effective mode of delivering ionized antiinflammatory drugs to inflamed tissues. It is effective, painless, and safe, and provides a viable treatment. J Orthop Sports Phys Ther 1982;4(2):109-112.

Entities:  

Year:  1982        PMID: 18810109     DOI: 10.2519/jospt.1982.4.2.109

Source DB:  PubMed          Journal:  J Orthop Sports Phys Ther        ISSN: 0190-6011            Impact factor:   4.751


  5 in total

Review 1.  Optimisation of treatment by applying programmable rate-controlled drug delivery technology.

Authors:  Yie W Chien; Senshang Lin
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  lontophoretic Devices for Drug Delivery.

Authors:  P Tyle
Journal:  Pharm Res       Date:  1986-12       Impact factor: 4.200

3.  Microdialysis and delivery of iontophoresis-driven lidocaine into the human gastrocnemius muscle.

Authors:  Mark Coglianese; David O Draper; Joseph Shurtz; Gary Mark
Journal:  J Athl Train       Date:  2011 May-Jun       Impact factor: 2.860

Review 4.  Achilles tendon injuries in athletes.

Authors:  M Kvist
Journal:  Sports Med       Date:  1994-09       Impact factor: 11.136

5.  In vitro optimization of dexamethasone phosphate delivery by iontophoresis.

Authors:  Jean-Philippe Sylvestre; Richard H Guy; M Begoña Delgado-Charro
Journal:  Phys Ther       Date:  2008-08-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.